期刊文献+

诱导血管平滑肌细胞FRP基因表达的机制研究 被引量:3

The Research of Daidzein Induces Follistatin Related Protein Expression in Vascular Smooth Muscle Cells
下载PDF
导出
摘要 目的:细胞基质蛋白FRP(Follistatin related protein,FRP)具有调节细胞增殖与迁移的功能,探讨诱导体外培养血管平滑肌细胞表达FRP的机制研究。方法:分离培养脐动脉和人乳内动脉血管平滑肌细胞(vascularsmooth muscle cell,VSMC);确定植物雌激素类药物大豆苷元抑制VSMC增殖的最佳作用时间与浓度;鉴定雌激素受体α、β;给予大豆苷元、17-β雌二醇和雌激素受体完全阻断剂ICI182780刺激细胞,进行竞争性反转录PCR、Northern Blot和原位杂交探讨药物诱导FRP表达途径。结果:大豆苷元可抑制两种VSMC的增殖;脐动脉VSMC表达雌激素受体α,人乳内动脉VSMC表达受体α、β;大豆苷元和雌激素可显著诱导FRP在两种不同VSMC中的表达,ICI182780可抑制大豆苷元的诱导作用。结论:细胞基质蛋白FRP可被雌激素类药物通过其受体诱导。 Objective:The present research uses cultured vascular smooth muscle cells as object;to explore the mechanism of daidzein inducing Follistatin related protein(FRP) expression.Methods:Culture human umbilical artery smooth muscle cells,and human mammary internal artery in vitro;identify the estrogen receptor in both type of VSMCs;estimate cellular activity and detect the state of cellular proliferation to find the most effective concentration and time of daizein;explore the mechanism FRP expression by methods of competitive PCR and Northern blot,after stimulated by daidzein,estradiol,or with estrogen receptor blocker ICI182780.Result:Daidzein can inhibit both type of VSMCs proliferation;human umbilical artery smooth muscle cells express estrogen receptor α,and human mammary internal artery express estrogen receptor α and β;daidzein and estradiol can induce FRP expression in both type of VSMCs,the receptor blocker inhibits the induction.Conclusion:Daidzein can induce of FRP expression through estrogen like pathway.
出处 《中华中医药学刊》 CAS 2009年第2期286-289,共4页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(30600229)
关键词 卵泡抑素相关蛋白 大豆苷原 雌激素 血管平滑肌 Follistatin related protein Diadzein Estrogen Vascular smooth muscle cell
  • 相关文献

参考文献2

二级参考文献35

  • 1[1]Middleton E Jr,Kandaswanmi C,Heoharidis TC.The impact of plant flavonoids on mammalian biology:implications for inflammations,heart disease and cancer[J].Pharmacol Rev,2000,52(4):673.
  • 2[2]Harborne JB,Williams CA.Advances in flavonoid research since 1992[J].Phytochemistry,2000,55(6):481.
  • 3[3]Griffths K,Denis L,Turkes A,et al.Phytoestrogens and diseases of the prostate gland[J].Baillieres Clin Endocrinol Metab,1998,12:625.
  • 4[4]Powis G.Signaling pathways as targets for anticancer drug development[J].Pharmacol Ther,1994,62:57.
  • 5[5]Lee LT,Huang YT,Hwang JJ,et al.Blockade of epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells[J].Anticancer Res,2002,22:1615.
  • 6[6]Wagner U,Sauter G,Moch H,et al.Patters of p53,erbB-2,and EGF-r expression in premalignant lesions of the urinary bladder[J].Hum Pathol,1995,26:970.
  • 7[7]Su SJ,Lai MD,Yeh TM,et al.Overexpression of HER-2/neu enhances the sensitivity of human bladder cancer cells to urinary isoflavones[J].Eur J Cancer,2001,37:1413.
  • 8[8]Kuriu A,Ikeda H,Kanakura Y,et al.Proliferation of human myeloid leukemia cell line associated with the tyrosine phosphorylation and activation of the proto-oncogene c-kit product[J].Blood,1991,78:2834.
  • 9[9]Carlo-Stella C,Dotti G,Mangoni L,et al.Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor gensitein[J].Blood,1996,88(8):3091.
  • 10[10]Marone M,D'Andrilli G,Das N,et al.Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases[J].Exp Cell Res,2001,270:1.

共引文献11

同被引文献47

  • 1Hambrock HO, Kaufmann B, Muller S, et al. Structural characterization of TSC-36/Flik-Analysis of two charge isoforms[J]. J Biol Chem, 2004, 279(12): 11727-11735.
  • 2Tanaka M, Ozaki S, Osakada F, et al. Cloning of follistatin- related protein as a novel autoantigen in systemie rheumatic diseases[J]. Int Immunol, 1998, 10(9): 1305-1314.
  • 3Adams D, Larman B, Oxburgh L. Developmental expression of mouse Follistatin-like 1 (Fstll): Dynamic regulation during organogenesis of the kidney and lung [J]. Gene Exp Patterns, 2007, 7(4): 491-500.
  • 4Yang Y, Liu JH, Mao HH, et al. The expression pattern of Follistatin-like 1 in mouse central nervous system development[J]. Gene Exp Patterns, 2009, 9(7): 532-540.
  • 5Dal-Pra S, Furthauer M, Van-Celst J, et al. Nogginl and Follistatin-like 2 function redundantly to Chordin to antagonize BMP activity[J]. Dev Biol, 2006, 298(2): 514-526.
  • 6Umezu T, Yamanouchi H, Iida Y, et al. Follistatin-like-1, a diffusible mesenchymal factor determines the fate of epithelium[J]. Proe Natl Aead Sci USA, 2010, 107(10): 4601--4606.
  • 7Sumitomo K, Kurisaki A, Yamakawa N, et al. Expression of a TGF-betal inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines[J]. Cancer Lett, 2000, 155(1): 37-46.
  • 8Mashimo J, Maniwa R, Sugino H, et al. Decrease in the expression of a novel TGF betal-inducible and ras- recision gene, TSC-36, in human cancer cells [J]. Cancer Lett, 1997, 113(1/2): 213-219.
  • 9Shibanuma M, Mashimo J, Mita A, et al. Cloning from a mouse osteoblastic cell line of a set of transforming- growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide[J]. Eur J Biochem, 1993, 217(1): 13-19.
  • 10Ouchi N, Oshima Y, Ohashi K, et al. Folhstatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric- oxide synthase-dependent mechanism [J]. J Biol Chem, 2008, 283(47): 32802- 32811.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部